SOURCE: Pyng Medical Corp.

June 28, 2005 09:00 ET

European Expansion for the F.A.S.T.1 System

VANCOUVER, BC -- (MARKET WIRE) -- June 28, 2005 -- Building on our USA market success, Pyng Medical Corp (OTC BB: PYNGF) (TSX-V: PYT) is aggressively investing and expanding their sales and marketing efforts into Europe, in both the civilian and military markets. Pyng Medical Corp is now well positioned to enter into this large potential market with all regulatory approvals in place, specifically CE Mark and ISO 13485.

With 25 member countries currently, and a population in excess of 457 million, Europe represents the world's largest trading block, and has a highly sophisticated emergency medical system. The European medical device market is estimated at about 55.2 billion Euros (Euromed Stat) which represents 30% of the global market, and is among the top three markets for medical technology.

We are in the process of selecting additional distributors in key European countries.

The status of our current distribution network is summarized below.

* United Kingdom:  Fenton Pharmaceuticals
* Austria:         Medical Sales Consultants
* Germany          Medical Sales Consultants
* Belgium          INNOMED
* Spain            ORTO-MEDIMATEC
* Portugal         ORTO-MEDIMATEC
* Norway:          EQUIP NOR NS direct to the Norwegian military
We have already achieved initial sales successes in prestigious key military organizations in the U.K., Germany, and Norway and key emergency medical organizations in England, Austria, Holland, and Belgium.

Pyng Medical Corp will continue to enhance its distribution opportunities and expand the awareness of our products through major medical conferences and sales visits in the European Union. The FAST1 System will be featured, three times daily, in a full trauma moulage at the AMBEX, the U.K.'s largest emergency medical conference, in Harrogate, England, where over 4,000 emergency medical personal are expected to attend.

For further information please contact Pyng Medical Corp. at 1-604-303-7964 or visit our web site at

Michael W. Jacobs, Chairman, Pyng Medical Corp

The Toronto Venture Exchange has neither reviewed nor approved of the contents of this News Release. Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction, and potential advantages of the F.A.S.T.1™ System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Medical Corp. reports on file with the TSX-V and the U.S. Securities and Exchange Commission.

Contact Information

  • Contact:
    Michael W. Jacobs
    Pyng Medical Corp.